![Pathogenesis of alpha-1 antitrypsin deficiency in the liver: new approaches to old questions - MedCrave online Pathogenesis of alpha-1 antitrypsin deficiency in the liver: new approaches to old questions - MedCrave online](https://medcraveonline.com/JLRDT/images/JLRDT-02-00023-g002.png)
Pathogenesis of alpha-1 antitrypsin deficiency in the liver: new approaches to old questions - MedCrave online
![SciELO - Brasil - Deficiência de alfa-1 antitripsina: diagnóstico e tratamento Deficiência de alfa-1 antitripsina: diagnóstico e tratamento SciELO - Brasil - Deficiência de alfa-1 antitripsina: diagnóstico e tratamento Deficiência de alfa-1 antitripsina: diagnóstico e tratamento](https://minio.scielo.br/documentstore/1806-3756/V95LLsmW8BLk8dX7dpB8Sxt/4bac51574a18be3c7c5805cf7274a0423f92be7a.gif)
SciELO - Brasil - Deficiência de alfa-1 antitripsina: diagnóstico e tratamento Deficiência de alfa-1 antitripsina: diagnóstico e tratamento
![Avraham Z. Cooper, MD on Twitter: "1/15 Why does alpha-1 antitrypsin deficiency (A1AT) cause liver disease (e.g. cirrhosis or hepatocellular carcinoma)? I always assumed the mechanism was the same as for lung Avraham Z. Cooper, MD on Twitter: "1/15 Why does alpha-1 antitrypsin deficiency (A1AT) cause liver disease (e.g. cirrhosis or hepatocellular carcinoma)? I always assumed the mechanism was the same as for lung](https://pbs.twimg.com/media/EbmpHbYWAAAUBYX.png)
Avraham Z. Cooper, MD on Twitter: "1/15 Why does alpha-1 antitrypsin deficiency (A1AT) cause liver disease (e.g. cirrhosis or hepatocellular carcinoma)? I always assumed the mechanism was the same as for lung
![Figure 4 from Alpha-1- Antitrypsin Deficiency Liver Disease: Science and Therapeutic Potential 50 Years Later (A Report from an International Research Conference on Alpha-1-AT) | Semantic Scholar Figure 4 from Alpha-1- Antitrypsin Deficiency Liver Disease: Science and Therapeutic Potential 50 Years Later (A Report from an International Research Conference on Alpha-1-AT) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/061b45d9b1e40500b2e7e7bd43da813cd9075092/2-Figure1-1.png)